Back to catalogue
№ 010 27 filings · 2021-06-10 → 2026-02-05

ARTEMIS UK FUTURE LEADERS PLC

AFL
Financial Services Market cap £106m Overall fit 320 /1000

Valuation discipline is satisfied (clear discount to underlying NAV of quality small caps) but this vehicle is a poor fit for the investor's AI-receiver and operating-leverage pillars — at the trust level there is essentially no operating leverage and AI exposure is incidental via a handful of small portfolio positions.

Fair value range 400p–525p Mid case · £141m
Absolute upside +33.1% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Level-1 quoted portfolio gives a clean NAV-based methodology
  • Board has track record of discount management (Oct 2024 elective special dividend at 97.5% of NAV)
  • Underlying portfolio holdings are cash-generative, market-leading UK small caps
Limits the call
  • No NAV disclosure in filings later than 31 Jul 2024; current NAV must be inferred
  • Implied current discount is wider than historical range, suggesting unrecorded portfolio moves or capital actions
Methodology

NAV less historical discount (8-16%)

In one line · bull case

A diversified portfolio of cash-generative UK small caps available via a closed-end vehicle at a wider-than-normal discount to NAV, with a refreshed Artemis mandate as a potential re-rating catalyst.

In one line · biggest risk

Continued UK small-cap de-rating combined with style-drift execution risk under a brand-new manager could keep the discount stuck or widen it further.

Drivers
AI beneficiary 25 /100
Diversified UK small-cap portfolio; only a handful of names (Kainos, Oxford Instruments, GlobalData, Aptitude) have direct AI-tooling exposure and they are sub-3% positions each.
Operating leverage 18 /100
Investment trust costs scale linearly with NAV (0.75% management fee on gross assets); ~£500k of true fixed costs is immaterial against a £100m+ NAV.
Earnings vs expectations 45 /100
Mixed NAV-vs-benchmark record: two beats and two misses in the disclosed periods; pre-Artemis Invesco team underperformed during the 2022-23 drawdown.
Growth momentum 45 /100
NAV growth has tracked benchmark roughly in line over multi-year periods; dividend held flat at 15.4p across the disclosed period.
Moat 25 /100
Closed-end trust structure with a 1% ongoing charge competes against passive small-cap ETFs and lower-cost peer trusts; no durable advantage.
Earnings quality 80 /100
All Level-1 quoted investments; unqualified audit by EY; transparent NAV reporting and clear capital/revenue split.
Management quality 55 /100
Mandate just transferred from Invesco to Artemis (Mar 2025); board has been pragmatic on discount control but no track record yet for the new manager on this vehicle.
Cyclicality 60 /100
UK small caps are economically sensitive and the portfolio explicitly runs a barbell of cyclical and defensive names.
Leverage 25 /100
Modest net gearing of ~4.5% via a £20m revolving facility; effectively a fortress balance sheet by operating-company standards.
Value-trap signals · 3
  • Persistent double-digit discount to NAV through multiple cycles
  • Continuation vote in 2027 represents an event but not a guaranteed NAV crystallisation
  • Structural UK small-cap outflows reduce the natural buyer base

Investment Research Note — Artemis UK Future Leaders plc (AFL)

Executive summary

AFL is a UK listed closed-end investment trust (formerly Invesco Perpetual UK Smaller Companies Investment Trust; renamed and re-mandated to Artemis in March 2025) that owns a diversified portfolio of ~60–70 small- and mid-cap UK quoted companies. Across the period covered the underlying NAV has been roughly flat-to-positive (+13.8% NAV total return in H1 FY25, vs. benchmark +12.1%), with the trust paying a stable 15.4p ordinary dividend and an elective £16.4m special dividend in October 2024 that shrank the share count by ~10% to 30.44m. The single most important valuation observation is that AFL is a NAV vehicle — its fair value is the look-through value of a quoted UK small-cap portfolio, available at a persistent ~10–15% discount and currently apparently at a much wider discount given the £100m disclosed market cap 2024-10 half-year; 2024-09 result of special dividend offer.

Fair value estimate

Methodology: NAV-based, the appropriate methodology for an investment trust whose entire portfolio is Level-1 quoted securities. Fair value = estimated NAV per share, less a discount in line with the trust's historical range (8–16%).

Build-up:

  • Last reported NAV per share: 532.6p on 33,826,929 shares (= £180.2m total NAV) at 31 July 2024 2024-10 half-year.
  • Special dividend in October 2024 paid £16.4m at 484.85p on 3.38m cancelled shares, leaving 30,444,281 shares in issue. Post-special-dividend NAV ≈ £163.8m, i.e. ≈538p/share.
  • Subsequent ~19-month period (Oct 2024 → May 2026): no fresh NAV disclosure in the filings provided. Assuming portfolio appreciation in the range −5% to +15% (consistent with sideways-to-mildly-positive UK small-cap returns and managers running a modestly geared book), estimated current NAV is in the range ~500p–620p per share, mid ~560p.
  • Applying a 10–20% discount (the trust has rarely traded above NAV in this dataset): fair value range ≈400p – 525p per share.
  • Mid fair value ≈ 462p, implied market cap ≈ £141m on 30.44m shares.

Comparison to current: market cap £100.1m implies ~329p, which is roughly 35–40% below the mid of our estimated NAV — a much wider gap than the trust's typical discount, suggesting either an unusually wide current discount or further share-base/NAV movement not captured in the filings provided.

Absolute upside to mid fair value: ~+41% (range +15% to +60%). View: undervalued, but with the conviction caveat that the gap rests on inferred current NAV.

Sector context

The reported ICB classification is Financials / Financial Services. For an investment trust this is the standard bucket but tells you very little — the relevant comparison set is UK smaller-companies investment trusts, not operating financial firms. Direct listed peers include Aberforth Smaller Companies (ASL), BlackRock Smaller Companies (BRSC), Henderson Smaller Companies (HSL), and Rights & Issues IT (RIII). AFL's quality/growth profile is in line with peers: 60–70 stock portfolio, modest gearing (~5% net), 0.75% management fee, ~1% ongoing charges — competitive but not differentiated. Discount to NAV has historically been wider than the best-managed peers in the sector.

Investment thesis

  • Discount-to-NAV closure optionality. AFL trades at what appears to be a sharper-than-normal discount to its underlying small-cap portfolio. Historical discount has cycled between ~8% and ~17%, narrowing during favourable UK risk-on periods. The board has demonstrated willingness to act (£16.4m elective special dividend in October 2024 at 97.5% of NAV, 10% share cancellation) which provides a structural floor 2024-09 result of special dividend offer.
  • Manager turnover refresh. The mandate moved from Invesco (Brown/West) to Artemis in March 2025. Artemis is a stronger retail brand in UK equities and the rename ("UK Future Leaders") signals a more growth-tilted positioning that may attract incremental flows and discount narrowing 2025-03 change of name.
  • Quality underlying holdings at depressed UK small-cap multiples. Top holdings as of last full disclosure included JTC, 4imprint, AJ Bell, Hilton Food, Hill & Smith, Chemring, Advanced Medical Solutions — cash-generative, market-leading businesses with multi-year compounding records. The UK small-cap index trades at a meaningful valuation discount to history, and the portfolio offers exposure at a further discount via the NAV gap 2024-10 half-year.

Key risks

  • Mandate change execution risk. Artemis is a new manager on this vehicle (March 2025), with no track record on this specific portfolio. Style drift, increased turnover during repositioning, or initial underperformance could widen rather than narrow the discount 2025-03 change of name.
  • UK small-cap structural outflow risk. The asset class has suffered persistent retail and institutional outflows for several years; takeover activity has been a key support but new IPOs are scarce. A continued de-rating of UK small caps would pull NAV down even if discount narrows 2024-10 half-year — managers' commentary on takeover activity.
  • Continuation vote in 2027. Shareholders vote on the trust's continuation every three years (next vote 2027). A poor performance run-up to that vote could trigger wind-up at a discount 2024-10 half-year — Chairman's statement.

Operating leverage

This is the weakest fit with the investor's preferences. At the trust level, AFL has essentially no operating leverage — ongoing charges run at ~1% of NAV, of which 0.75% is a management fee that scales linearly with gross funds under management (it does NOT step down with scale). Fixed administrative costs (board, audit, registrar) are sub-£500k, so a +10–20% rise in NAV would translate roughly proportionally into a higher absolute fee bill and only a marginal improvement in the ongoing-charges ratio. Look-through, the portfolio does contain some operationally geared businesses (4imprint, AJ Bell, Kainos, software names) but these are diluted in a 60–70 stock book; a +20% revenue surprise at any one of them adds < 0.3% to NAV. The vehicle simply does not offer the kind of fixed-cost asymmetry the investor is looking for 2024-10 half-year — Investment management fee notes.

Value-trap signals

  • The wide implied discount to NAV is itself a possible signal — investment trusts can trade at structurally wide discounts for long periods when (a) the sector is out of favour or (b) liquidity is poor.
  • Continuation vote in 2027 creates an event but no guarantee of value crystallisation at NAV.
  • No related-party or accounting red flags. The portfolio is 100% Level-1 quoted.
  • Conclusion: discount is partly structural, but no terminal-decline signal.

Earnings vs. expectations

Investment trusts don't issue earnings guidance in the conventional sense, so the relevant comparison is NAV total return vs. benchmark. The pattern in the filings:

  • H1 FY25 (Jul 2024): NAV TR +13.8% vs. benchmark +12.1% (beat) 2024-10 half-year.
  • FY24 (Jan 2024): NAV TR −4.1% vs. benchmark −3.3% (slight miss) 2024-10 half-year retrospective.
  • H1 FY24 (Jul 2023): NAV TR −6.9% vs. benchmark −4.2% (miss) 2023-10 half-year.
  • FY23 (Jan 2023): NAV TR −17.5% vs. benchmark −12.4% (miss) 2023-10 half-year retrospective.
  • H1 FY23 (Jul 2022): NAV TR −11.3% vs. benchmark −12.0% (marginal beat) 2022-10 half-year.
  • H1 FY22 (Jul 2021): NAV TR +23.3% vs. benchmark +18.8% (beat) 2021-10 half-year.

Pattern: mixed, with two material periods of benchmark underperformance during the 2022–2023 small-cap drawdown and recovery in 2024. This is one reason the mandate was moved to Artemis.

Conviction

3 — moderate. The methodology (NAV) is unambiguous and converges to a single answer for a closed-end investment company. What anchors moderate conviction is (i) the portfolio is 100% Level-1 quoted at fair value, (ii) the trust's discount is a well-disclosed observable, (iii) board has demonstrated willingness to manage the discount via tender/special dividends. What limits conviction is (i) the filings provided do not include a recent NAV reading post-September 2024, so the precise current NAV is estimated rather than observed, and (ii) the disclosed £100.1m market cap implies a wider-than-normal discount that may reflect material information not in this filing pack (e.g. further capital returns, or material NAV decline).

Filings consulted · 26

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-02-05Dividend Declaration2026-02-05_9411163_dividend-declaration.md0.30
  2. 2025-10-09Dividend Declaration2025-10-09_9161359_dividend-declaration.md0.26
  3. 2025-07-16Dividend Declaration2025-07-16_8982344_dividend-declaration.md0.26
  4. 2025-03-14Change OF Name2025-03-14_8780336_change-of-name.md0.39
  5. 2025-02-05Dividend Declaration2025-02-05_8723213_dividend-declaration.md0.20
  6. 2024-10-16Half Year Report2024-10-16_8488620_half-year-report.md0.58
  7. 2024-10-08Dividend Declaration2024-10-08_8473250_dividend-declaration.md0.20
  8. 2024-09-18Result OF Special Dividend Offer2024-09-18_8424118_result-of-special-dividend-offer.md0.20
  9. 2024-08-20Result OF Special Dividend Offer2024-08-20_8374537_result-of-special-dividend-offer.md0.20
  10. 2024-07-18Dividend Declaration2024-07-18_8319332_dividend-declaration.md0.20
  11. 2024-06-06Result OF Agm2024-06-06_8247146_result-of-agm.md0.20
  12. 2024-02-02Dividend Declaration2024-02-02_8020224_dividend-declaration.md0.14
  13. 2023-10-11Half Year Report2023-10-11_7808975_half-year-report.md0.41
  14. 2023-10-11Dividend Declaration2023-10-11_7809019_dividend-declaration.md0.14
  15. 2023-07-20Dividend Declaration2023-07-20_7644849_dividend-declaration.md0.14
  16. 2023-06-08Result OF Agm2023-06-08_7566903_result-of-agm.md0.14
  17. 2023-02-02Dividend Declaration2023-02-02_7353866_dividend-declaration.md0.07
  18. 2022-10-07Half Year Report2022-10-07_7252415_half-year-report.md0.23
  19. 2022-10-07Dividend Declaration2022-10-07_7252862_dividend-declaration.md0.07
  20. 2022-07-19Dividend Declaration2022-07-19_7079550_dividend-declaration.md0.07
  21. 2022-06-09Result OF Agm2022-06-09_6875200_result-of-agm.md0.07
  22. 2022-02-10Dividend Declaration2022-02-10_6801516_dividend-declaration.md0.07
  23. 2021-10-12Half Year Report2021-10-12_6762566_half-year-report.md0.23
  24. 2021-10-12Dividend Declaration2021-10-12_6763060_dividend-declaration.md0.07
  25. 2021-07-28Dividend Declaration2021-07-28_6782596_dividend-declaration.md0.07
  26. 2021-06-10Result OF Agm2021-06-10_6666764_result-of-agm.md0.07

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-06-10 and 2026-02-05. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.